HealthStream Inc (HSTM) is a publicly traded Healthcare sector company. As of November 3, 2026, HSTM trades at $35.05 with a market cap of $1.03B and a P/E ratio of 44.74. HSTM moved +2.98% today. Year to date, HSTM is +51.97%; over the trailing twelve months it is +40.79%. Its 52-week range spans $19.50 to $35.61. Analyst consensus is neutral with an average price target of $32.50. Rallies surfaces HSTM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
HealthStream raises 2026 outlook as Q3 revenue grows and net income falls: HealthStream raised its 2026 revenue, net income and adjusted EBITDA outlook after third-quarter revenue rose 8.9% to $83.3 million and adjusted EBITDA reached $19.3 million, both above estimates. Net income fell 12% to $5.4 million, and EPS declined to $0.18 from $0.20 as higher operating expenses weighed on earnings.
| Metric | Value |
|---|---|
| Price | $35.05 |
| Market Cap | $1.03B |
| P/E Ratio | 44.74 |
| EPS | $0.72 |
| Dividend Yield | 0.04% |
| 52-Week High | $35.61 |
| 52-Week Low | $19.50 |
| Volume | 187.69K |
| Avg Volume | 0 |
| Revenue (TTM) | $321.12M |
| Net Income | $21.20M |
| Gross Margin | 0.00% |
4 analysts cover HSTM: 0 strong buy, 1 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $32.50.